Home > Insider Trading > Filing (0001140361-17-000843)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1428336	Healthequity Inc	HQY	Services-Business Services, Nec (7389)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1614878	Frank Corvino	C/O Healthequity, Inc. 15 W. Scenic Pointe Dr., Ste. 100 Draper UT 84020		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-01-03	7,500	$14.00	7,500	No	4	M	Direct
Common Stock	Acquisiton	2017-01-03	12,500	$14.00	20,000	No	4	M	Direct
Common Stock	Acquisiton	2017-01-03	15,000	$25.39	35,000	No	4	M	Direct
Common Stock	Disposition	2017-01-03	31,400	$40.25	3,600	No	4	S	Direct
Common Stock	Disposition	2017-01-03	3,600	$41.01	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2017-01-03	7,500	$0.00	7,500	$14.00
Common Stock	Stock Option (right to buy)	Disposition	2017-01-03	12,500	$0.00	12,500	$14.00
Common Stock	Stock Option (right to buy)	Disposition	2017-01-03	15,000	$0.00	15,000	$25.39

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2024-07-30	No	4	M	Direct
12,500	2024-07-30	No	4	M	Direct
0	2025-03-26	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$21.27		2026-02-01	15,000	15,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2026-02-01	15,000	15,000	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.98 to $40.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.99 to $41.07, inclusive.
The option is immediately exercisable.
The option became exercisable as to 6,250 shares on June 30, 2015 and as to 6,250 on June 30, 2016. The option becomes exercisable as to the remaining 12,500 shares in two equal installments of 6,250 shares on June 30, 2017 and 2018.
The option became exercisable as to 7,500 shares upon the reporting person's reelection to the issuer's board of directors at the issuer's 2016 Annual Meeting of Stockholders held on June 23, 2016. The remaining 7,500 shares will become exercisable on January 31, 2017; provided, that the reporting person continues to serve as a director of the issuer through such date.